Rockall score for upper GI bleeding is a universally recognized, validated clinical prognostic scoring system designed to estimate the risk of rebleeding and mortality in patients presenting with acute upper gastrointestinal hemorrhage 1. By integrating baseline clinical parameters—such as patient age, hemodynamic stability, and major comorbid conditions—alongside specific endoscopic findings (including diagnosis and signs of recent hemorrhage), the Rockall score provides clinicians with an objective framework to guide triage, determine the urgency of therapeutic interventions, and allocate critical care resources effectively 1.

Etiology & Risk Factors

  • Peptic Ulcer Disease (PUD): Accounting for approximately 50% of all upper gastrointestinal bleeding episodes, involving gastric or duodenal ulcers exacerbated by Helicobacter pylori infection or mucosal erosion from non-steroidal anti-inflammatory drugs (NSAIDs) 1.
  • Erosive Gastritis and Duodenitis: Mucosal inflammation resulting from acute physiological stress, systemic inflammatory response, alcohol use, or chronic drug exposure 1.
  • Esophageal Varices: Submucosal portosystemic collaterals arising secondary to portal hypertension (typically from advanced cirrhosis), prone to catastrophic rupture and massive hemorrhage 1.
  • Mallory-Weiss Tears: Longitudinal mucosal lacerations at the gastroesophageal junction precipitated by severe retching, vomiting, or coughing 1.
  • Malignancies: Gastric adenocarcinoma, esophageal squamous cell carcinoma, or gastrointestinal stromal tumors (GISTs) causing friable, ulcerated mucosal lesions subject to chronic or acute bleeding 1.
  • Vascular Anomalies: Dieulafoy lesions (abnormally large submucosal arteries eroding through the mucosa) and gastric antral vascular ectasia (GAVE) 1.
  • Systemic Risk Factors: Advanced age, chronic kidney disease, coagulopathies, concurrent antiplatelet or anticoagulant therapy, and severe multi-organ comorbidities 1.

Pathophysiology

Acute upper gastrointestinal bleeding originates proximal to the ligament of Treitz, encompassing pathology within the esophagus, stomach, and duodenum. The fundamental pathophysiological cascade is initiated by structural disruption of the mucosal barrier or vascular integrity, exposing underlying submucosal arterial or venous blood vessels to gastric acid, pepsin, and mechanical shear stress. When arterial structures—such as the gastroduodenal artery in posterior duodenal ulcers—are eroded, high-pressure intraluminal hemorrhage ensues rapidly. The consequent loss of intravascular volume triggers homeostatic compensatory mechanisms, including sympathetically mediated vasoconstriction, tachycardia, and increased myocardial contractility, designed to maintain vital organ perfusion. However, if the rate of blood loss overwhelms compensatory responses, systemic arterial pressure drops, culminating in hemorrhagic shock, tissue hypoperfusion, and anaerobic cellular metabolism. In patients with chronic liver disease, variceal bleeding develops when elevated hepatic sinusoidal pressure expands collateral pathways in the lower esophagus and gastric cardia; these thin-walled vessels lack a supportive muscular layer and rupture easily under minor increases in intra-abdominal or intraluminal pressure, producing severe, unremitting hemorrhage independent of gastric acid.

Rockall score for upper GI bleeding — Pathophysiological Cascade & Clinical Flowchart 1 Acute Mucosal Insult or Vascular Lesion Rupture of submucosal vessels, peptic ulcer erosion, or Mallory-Weiss tear leading to acute intraluminal blood loss 2 Intraluminal Hemorrhage & Hypovolemic Stress Extravasation of blood into the upper gastrointestinal tract causing depletion of intravascular volume, compensatory tachycardia, and systemic hypoperfusion 3 Systemic Hemodynamic Compromise & Organ Malperfusion Sustained blood loss resulting in decreased tissue oxygen delivery, acute kidney injury, and myocardial stress in vulnerable individuals 4 Hallmark Clinical Manifestation Presentation with acute hematemesis, coffee-ground emesis, melena, or hematochezia accompanied by orthostatic hypotension and anemia 5 Rebleeding & Mortality Risk vs. Endoscopic Hemostasis Progression to hemorrhagic shock or recurrent bleeding mitigated by urgent risk stratification via the Rockall score and targeted endoscopic intervention

Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients classically present with hematemesis (bright red blood or "coffee-ground" emesis reflecting gastric acid oxidation of hemoglobin), melena (dark, tarry, foul-smelling stools indicating blood digested over at least 14 hours by enteric bacteria), or hematochezia in the setting of extremely brisk upper GI hemorrhage with rapid transit. Concomitant symptoms frequently include generalized fatigue, lightheadedness, syncope, dyspnea on exertion, and epigastric or retrosternal pain 1.
  • Physical Examination & Named Clinical Signs: Bedside evaluation focuses primarily on hemodynamic stability. Tachycardia (heart rate > 100 beats per minute) and orthostatic hypotension are early indicators of significant volume depletion (> 15% blood loss). Severe hypovolemia manifests as overt hypotension, cool clammy extremities, altered mental status, and delayed capillary refill. Abdominal examination may reveal epigastric tenderness in peptic ulcer disease, splenomegaly, ascites, caput medusae, and jaundice suggestive of portal hypertension and chronic liver disease. Stigmata of chronic liver disease (spider angiomas, palmar erythema) and digital rectal examination confirming melena are critical physical exam milestones 1.

Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationUrgent esophagogastroduodenoscopy (EGD) performed within 24 hours of admission; identifies exact bleeding source, categorizes Forrest classification of ulcers, and permits therapeutic hemostasis.
Laboratory PanelComplete Blood Count (CBC) showing normocytic or microcytic anemia (though hemoglobin may be normal initially due to acute hemoconcentration); elevated Blood Urea Nitrogen (BUN) to creatinine ratio (> 30:1) due to digestion and absorption of blood proteins in the small bowel and prerenal azotemia; coagulopathy evaluation via PT/INR, PTT, and fibrinogen; and baseline electrolyte and renal panels.
Imaging / Radiology (X-ray, US, CT, MRI)Contrast-enhanced multiphasic CT angiography (CTA) indicated in massive ongoing hemorrhage where endoscopy is obscured by blood or when surgical/interventional radiology embolization is contemplated; abdominal ultrasound to assess for chronic liver disease, portal hypertension, and portosystemic collaterals.
ECG / Histopathology / Procedural12-lead ECG to rule out myocardial ischemia or acute coronary syndrome secondary to demand ischemia (type 2 myocardial infarction) induced by acute blood loss and tachycardia; histopathological examination of endoscopic biopsies to evaluate for malignancy and confirm Helicobacter pylori infection.

Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Age (Years)< 60 years (0 points); 60–79 years (1 point); ≥ 80 years (2 points). Higher age strongly correlates with reduced physiological reserve and increased mortality.
Shock Status (Hemodynamics)No shock: Systolic BP ≥ 100 mmHg, Heart rate < 100 bpm (0 points); Tachycardia: Systolic BP ≥ 100 mmHg, Heart rate ≥ 100 bpm (1 point); Hypotension: Systolic BP < 100 mmHg (2 points). Reflects degree of acute intravascular volume depletion.
ComorbidityNo major comorbid illness (0 points); Cardiac failure, ischemic heart disease, or major morbidity (2 points); Renal failure, liver failure, or disseminated malignancy (3 points). Quantifies baseline vulnerability to physiological stress.
Endoscopic DiagnosisMallory-Weiss tear, no pathology identified, or no spots of recent hemorrhage (0 points); All other diagnoses such as gastric or duodenal ulcer, erosions, esophagitis (1 point); Upper GI malignancy (2 points). Establishes inherent lesion bleeding risk.
Major Stigmata of Recent Hemorrhage (SRH)None or dark spot only (0 points); Blood in upper GI tract, active bleeding, visible vessel, or adherent clot (2 points). Guides immediate requirement for endoscopic hemostasis and post-procedure intensive monitoring.
Total Rockall Score InterpretationPre-endoscopy score ranges from 0 to 7; full score ranges from 0 to 11. A total score ≤ 2 indicates low risk of rebleeding and mortality (favorable prognosis), whereas a score ≥ 6 signifies high risk requiring aggressive resuscitation, prompt endoscopic therapy, and close monitoring in a high-dependency or intensive care unit setting.

Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Lower Gastrointestinal BleedingPresentation typically with hematochezia or maroon stools rather than melena or hematemesis; upper gastrointestinal endoscopy is negative; nasogastric aspirate is clear and negative for blood.
HemoptysisExpectoration of bright red, frothy blood coughed up from the respiratory tract; usually preceded by pulmonary symptoms, abnormal chest imaging, and negative gastrointestinal endoscopic findings.
Pseudo-Melena (Dietary or Pharmacological)Dark stools caused by ingestion of bismuth subsalicylate, iron supplementation, blueberries, or activated charcoal; stool occult blood test (guaiac or immunochemical) is negative, and systemic signs of acute blood loss are absent.
Aortoenteric FistulaCatheterization or catastrophic upper GI hemorrhage in patients with a history of abdominal aortic aneurysm repair or aortic graft placement; classically presents with a "sentinel bleed" followed by massive exsanguinating hemorrhage; diagnosed via urgent contrast-enhanced CT angiography.

Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Immediate assessment and maintenance of the airway, breathing, and circulation (ABCs). Establish large-bore peripheral intravenous access (two 18-gauge or larger lines) or central venous access. Administer rapid crystalloid fluid resuscitation (normal saline or lactated Ringer's); transfuse packed red blood cells (PRBCs) targeting a conservative hemoglobin threshold of 7.0 g/dL (or 8.0 g/dL in patients with pre-existing cardiovascular disease). Correct severe coagulopathies or thrombocytopenia with fresh frozen plasma, platelets, or prothrombin complex concentrates as indicated. For patients with suspected variceal bleeding, initiate vasoactive drug therapy (somatostatin, octreotide, or terlipressin) immediately upon presentation prior to endoscopy.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing): Administer high-dose intravenous proton pump inhibitor (PPI) therapy immediately for suspected non-variceal upper GI bleeding: pantoprazole or esomeprazole 80 mg IV bolus, followed by a continuous infusion of 8 mg/h for 72 hours. For suspected variceal bleeding, administer octreotide 50 mcg IV bolus followed by a continuous infusion of 50 mcg/h for 2 to 5 days, alongside empiric antibiotic prophylaxis with intravenous ceftriaxone 1 g every 24 hours (or norfloxacin 400 mg orally twice daily) to prevent spontaneous bacterial peritonitis and infection-related mortality in cirrhotic patients.
  • Surgical / Interventional Indications: Urgent therapeutic EGD within 24 hours of presentation using thermal coagulation, hemoclips, or injection therapy (epinephrine combined with sclerosant) for high-risk bleeding stigmata. If endoscopic hemostasis fails or is technically unfeasible due to massive active hemorrhage, proceed immediately to transcatheter arterial embolization (TAE) via interventional radiology or surgical intervention (e.g., ulcer oversewing, gastrectomy, or shunt procedures for refractory varices).

Complications & Prognosis

  • Key acute complications include recurrent hemorrhage (rebleeding), hypovolemic shock, aspiration pneumonia, cardiac arrhythmias, myocardial infarction, and acute kidney injury secondary to sustained prerenal azotemia. Chronic complications are primarily related to underlying chronic liver disease (hepatic encephalopathy, hepatorenal syndrome) or recurrent anemia. Overall mortality for acute upper gastrointestinal bleeding ranges from 2% to 10%, but rises steeply in elderly patients and those with high Rockall scores (scores ≥ 6), underscoring the vital prognostic utility of the Rockall scoring system in identifying high-risk cohorts requiring aggressive multidisciplinary management 1,3.